Jump to page content

Search results

  • Publication

    New study evaluates DeepSeek for clinical decision making

    BIH researchers and colleagues showed that public large-language models, such as DeepSeek, perform as well as proprietary models (e.g. GPT4o) that cannot be used for patient data. They can therefore be used for clinical decisions in routine care.

  • Press release Team of the BIH Clinical Incubator

    BIH Partners With BioLabs to Launch Clinical Incubator for Biomedical Translation Of Advanced Therapy Medicinal Products (ATMPs)

    Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office workspaces, to support operations at the full-service BIH…

  • Publication News In vivo quantitative MRI scans reveal swelling-associated changes when comparing a healthy participant (left) with a patient diagnosed with mid-portion Achilles tendinopathy (right).

    Study on biomechanics: Novel mechanism uncovered in tissue

    Researchers from the Berlin Institute of Health at Charité (BIH), the Center for Musculoskeletal Surgery at Charité – Universitätsmedizin Berlin, Friedrich Schiller University Jena, ETH Zurich and the Max Planck Institute of Colloids and Interfaces have uncovered a novel mechanism that links the water-binding properties of the extracellular matrix…

  • Publication Mpox virus, colored green

    Study yields new data on Mpox vaccine effectiveness

    A study under the leadership of Prof. Leif Erik Sander has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. The results of the study have now been published in The Lancet Infectious Diseases.

  • Partner press release Publication Heart biopsy tissue from a patient with COVID-19.

    Not all heart inflammation is the same

    A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccination, and non-COVID-19 myocarditis. The find paves the way for more personalized therapies, they report in “Nature Cardiovascular Research.”

  • Press release Portrait photo Maik Pietzner

    Maik Pietzner receives professorship for “Health Data Modeling”

    Dr. Maik Pietzner receives a W2 professorship for life for “Health Data Modeling” at the Berlin Institute of Health at Charité (BIH). His aim is to find disease-specific small changes in genes and thus target structures for innovative drugs. Using machine learning (ML) to mine huge amounts of heterogenous data sources, he wants to identify new…

  • Press release Charité BIH Innovation Recovery Cat Team: From left to right: Alissa Maresa Rohrbach, Jakob Kaminski, Toni Muffel, Dennis Stratmann, Elisabeth Kress, Hanhoan Truong, Katrin Friedmann, Felix Machleid

    Recovery Cat, an app that helps with the treatment of severe mental illnesses, is now available to TK insurees

    Recovery Cat is an app that provides digital therapy support to people with severe mental illnesses. Effective immediately, patients who are insured with Techniker Krankenkasse (TK) can use the Recovery Cat service free of charge. Further insurances will follow. A spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health…

Press contact

Konstanze Pflüger

Head of Communications and Press Officer

Contact information
Phone:+49 (0)30 450 543 343
E-mail:pressestelle-bih@bih-charite.de